BERLIN -- Almost half of patients with advanced ALK -positive non-small cell lung cancer (NSCLC) have lived 7 years or longer ...

Backpacking is a relatively low-entry sport for cost and equipment. There are some basic measures on and off the trail that ...

Explore Madonna University course and discover the d‌etailed admiss‌ion requirem⁠ents and their straightforward a​p‍plication ...

More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...

What we’re really watching is the quiet construction of a new border wall — not of steel, but of gold bricks. Trump’s first ...

The East Point Dollar Tree has developed something of a cult following among savvy shoppers across the Peach State. While every Dollar Tree carries similar merchandise, regulars swear this location ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

The AI boom has brought with it a new crop of startups looking to build a business on an urgent but vaguely dystopian idea: ...

Positive results from the DESTINY-Breast05 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in ...

Workout regulars are training like elites to find purpose, community, and proof of what their bodies can do. This movement may be the ultimate antidote to life in 2025.

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

The goal of longevity science is not just to extend lifespan but to extend healthspan, delaying or reducing the chronic ...